Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Goldman Sachs Maintains Neutral on Equifax, Raises Price Target to $307

Author: Benzinga Newsdesk | August 20, 2024 01:59pm
Goldman Sachs analyst George Tong maintains Equifax (NYSE:EFX) with a Neutral and raises the price target from $277 to $307.

Posted In: EFX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist